Genus Lifesciences Inc. v. Lannett Company, Inc.
1:20-cv-00770
Overview
Parties
Defendant
Lannett Company, Inc. Operating Company
Represented By
8 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Plaintiff
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 9 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9867815
Pharmaceutical compositions and methods of using the same
|
Filed: 2017-03-27
Issued: 2018-01-16
|
Active (10.3 yrs remaining)
Expires: 2037-03-27
|
|
|
US10016407
Pharmaceutical compositions and methods of using the same
|
Filed: 2017-12-20
Issued: 2018-07-10
|
Active (11.1 yrs remaining)
Expires: 2037-12-20
|
|
|
US10420760
Pharmaceutical compositions and methods of using the same
|
Filed: 2018-03-26
Issued: 2019-09-24
|
Active (10.2 yrs remaining)
Expires: 2037-02-18
|
|
|
US10857095
Pharmaceutical compositions and methods of using the same
|
Filed: 2020-06-29
Issued: 2020-12-08
|
Active (13.6 yrs remaining)
Expires: 2040-06-29
|
|
|
US10894012
Pharmaceutical compositions and methods of using the same
|
Filed: 2020-06-17
Issued: 2021-01-19
|
Active (13.6 yrs remaining)
Expires: 2040-06-17
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
28
Dispositive
22
Granted
0
Denied
0
Pending / Review
21
Motions by Category
Key Dispositive Motions & Rulings